Eli Lilly and Company DSO Ratio 2011-2026 | LLY

Annual DSO Ratio Eli Lilly and Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
80.5	81.4	85.5	86.8	80.9	77.5	90.6	92.2	84	82	74.5	70.7	63.5	62.8	63.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
92.2	62.8	78.4

Quarterly DSO Ratio Eli Lilly and Company

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
76.9	80	85	76.3	83.5	75.3	82.6	94.5	-	44.1	44.5	75.9	-	79.1	77.3	76.9	-	93.4	97.5	81.2	67.9	75.8	73.6	81.9	74.4	79	75.1	78.8	71.9	83.6	81.5	86.7	63.8	70.8	68	70.7	59.6	64.6	64.4	66.3	57.6	60.5	59.8	65	54	54.3	52.9	55.1	51.1	55.9	54.4	56.5	-	53.4	52.5	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
97.5	44.1	69.9

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Amarin Corporation plc AMRN	213	$ 14.67	-0.07 %	$ 6.09 B	Irlanda
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
CEL-SCI Corporation CVM	227	$ 3.47	-1.7 %	$ 221 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Denali Therapeutics DNLI	1.89	$ 19.74	-12.17 %	$ 3.25 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Equillium EQ	16.6	$ 2.06	-	$ 118 M	USA
Esperion Therapeutics ESPR	99.7	$ 2.85	3.26 %	$ 592 M	USA
Eton Pharmaceuticals ETON	39.1	$ 23.45	-1.64 %	$ 631 M	USA
China SXT Pharmaceuticals SXTC	318	$ 1.32	-5.2 %	$ 1.88 M	China
CRISPR Therapeutics AG CRSP	1.1 K	$ 47.55	0.98 %	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	50	$ 4.45	-1.77 %	$ 853 M	Canada